Results 81 to 90 of about 10,082 (205)

Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes

, 2009
Paul ValensiDepartment of Endocrinology-Diabetology-Nutrition, Jean Verdier Hospital, AP-HP, Paris Nord University, CRNH-IdF, Bondy, FranceAbstract: The pharmacological advantages of the rapid-acting analog, insulin aspart, over human insulin have ...
Paul Valensi
core  

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Southwest Saudi Arabia cohort of the A 1 chieve study

Indian Journal of Endocrinology and Metabolism, 2013
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care ...
Waffaa Shawkat, Magdy Abdou, Nadia Ghannam, Ashraf Shaaban Mahfouz   +3 more
doaj   +1 more source

Use of fast-acting insulin aspart in insulin pump therapy in clinical practice

, 2019
Fast-acting insulin aspart (faster aspart) is a novel formulation of insulin aspart (IAsp) containing the additional excipients niacinamide and L‐arginine.
Evans, Mark, Wilmot, Emma,, Christophe De Block, DeVries, J. H., Lind, Marcus, Renard, E., Norgaard, Kirsten, Ceriello, A., Mathieu, C., Marcus Lind, Ceriello, Antonio, De Block, C., Wilmot, E. G., Antonio Ceriello, J. Hans DeVries, Renard, Eric, Thomas Danne, Eric Renard, Kirsten Nørgaard, Mark Evans, de Block, Christophe, Wilmot, Emma, G, Chantal Mathieu, Danne, Thomas, Danne, T., DeVries, J. Hans, Wilmot, Emma G., Mathieu, Chantal, Lind, Marcus,, Nørgaard, Kirsten, Evans, M., Emma G. Wilmot, Nørgaard, K.   +32 more
core   +2 more sources

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Rajasthan cohort of the A 1 chieve study

Indian Journal of Endocrinology and Metabolism, 2013
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care ...
Akhil Joshi, Anand Meenawat, Rajeev Patni, D C Sharma, Shashi Panicker   +4 more
doaj   +1 more source

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Saiss cohort of the A 1 chieve study

Indian Journal of Endocrinology and Metabolism, 2013
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66 726) in routine clinical care ...
Farida Ajdi
doaj   +1 more source

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the East India cohort of the A 1 chieve study

Indian Journal of Endocrinology and Metabolism, 2013
Background: The A1chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care ...
Abhay Kumar Sahoo, Sambit Das, Pitambar Prusty, Anand Shankar, Shaibal Guha   +4 more
doaj   +1 more source

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Yemen cohort of the A 1 chieve study

Indian Journal of Endocrinology and Metabolism, 2013
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care ...
Zayed Atef, Abdulkareem Al-Khawlany, Abdalla A Gunaid   +2 more
doaj   +1 more source

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the North East India cohort of the A 1 chieve study

Indian Journal of Endocrinology and Metabolism, 2013
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care ...
Debmalya Sanyal, Debasis Basu, Mihir Saikia   +2 more
doaj   +1 more source

Aspartate in the Brain: A Review

Neurochemical Research
Abstract l-Aspartate (aspartic acid; C4H7NO4; 2-aminobutanedoic acid) is a non-essential α-amino acid found ubiquitously throughout the body, including in the brain. Aspartate is one of the protein-forming amino acids and the formation of tRNA-aspartate complex is catalysed by aspartyl tRNA synthetase.
Caroline D. Rae, Benjamin D. Rowlands, Vladimir J. Balcar   +2 more
openaire   +2 more sources

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from North and the oriental region of Morocco cohort of the A 1 chieve study

Indian Journal of Endocrinology and Metabolism, 2013
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66 726) in routine clinical care ...
Othmane Laaribi
doaj   +1 more source